Materials and methods for minimally-invasive administration of a cell-containing flowable composition

Materials and methods for minimally-invasive administration of a cell-containing flowable composition

  • CN 101,076,360 B
  • Filed: 12/06/2005
  • Issued: 11/13/2013
  • Est. Priority Date: 12/08/2004
  • Status: Active Grant
First Claim
Patent Images

1. treat the flowable compositions of the impaired or disease sites of tubular anatomical structures inner chamber, wherein said flowable compositions comprises biocompatible matrix and endotheliocyte, wherein said endotheliocyte is paved with, that closely be paved with or be paved with after and be implanted on described biocompatible matrix, among and/or within, and described biocompatible matrix comprises microgranule or microcarrier, and described microgranule or microcarrier further comprise gelatin, collagen protein, fibronectin, fibrin, laminin,

  • LN

    , or be selected from the attaching peptide of the peptide of sequence arginine-Gly-Asp (RGD), but described flow composition is delivered to impaired by percutaneous injection or disease sites or near chamber outer surface adjacent with this position or this position, and the amount of described flowable compositions is the amount of impaired or disease sites of effectively treating.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×